Literature DB >> 25179825

Drug metabolism in microorganisms.

Cormac D Murphy1.   

Abstract

Several wild type and recombinant microorganisms can transform drugs to the equivalent human metabolites. Fungi, such as Cunninghamella spp., and Streptomyces bacteria express cytochrome P450 (CYP) enzymes that enable analogous phase I (oxidative) reactions with a wide range of drugs. The gene encoding the bifunctional CYP102A1 in Bacillus megaterium can be expressed easily in E. coli, and extensive mutagenesis experiments have generated numerous variants that can produce human drug metabolites. Additionally, human CYP isoforms have been expressed in various hosts. The application of microbial CYPs to the production of human drug metabolites is reviewed, and additional applications in the field of drug development are considered.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25179825     DOI: 10.1007/s10529-014-1653-8

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  8 in total

1.  Processing of NMR and MS metabolomics data using chemometrics methods: a global tool for fungi biotransformation reactions monitoring.

Authors:  Cécile Palaric; Serge Pilard; Jean-Xavier Fontaine; Julien Boccard; David Mathiron; Sébastien Rigaud; Dominique Cailleu; François Mesnard; Yoann Gut; Tristan Renaud; Alain Petit; Jean-Yves Beaumal; Roland Molinié
Journal:  Metabolomics       Date:  2019-07-25       Impact factor: 4.290

Review 2.  Cytochrome P450s in algae: Bioactive natural product biosynthesis and light-driven bioproduction.

Authors:  Shanmin Zheng; Jiawei Guo; Fangyuan Cheng; Zhengquan Gao; Lei Du; Chunxiao Meng; Shengying Li; Xingwang Zhang
Journal:  Acta Pharm Sin B       Date:  2022-01-24       Impact factor: 14.903

3.  Inactivation of β-Lapachone Cytotoxicity by Filamentous Fungi that Mimic the Human Blood Metabolism.

Authors:  Camila Raquel Paludo; Eduardo Afonso da Silva-Junior; Eliane de Oliveira Silva; Ricardo Vessecchi; Norberto Peporine Lopes; Mônica Tallarico Pupo; Flavio da Silva Emery; Natália Dos Santos Gonçalves; Raquel Alves Dos Santos; Niege Araçari Jacometti Cardoso Furtado
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.569

Review 4.  Accessing Nature's diversity through metabolic engineering and synthetic biology.

Authors:  Jason R King; Steven Edgar; Kangjian Qiao; Gregory Stephanopoulos
Journal:  F1000Res       Date:  2016-03-24

5.  The CYPome of the model xenobiotic-biotransforming fungus Cunninghamella elegans.

Authors:  William Palmer-Brown; Raúl Miranda-CasoLuengo; Kenneth H Wolfe; Kevin P Byrne; Cormac D Murphy
Journal:  Sci Rep       Date:  2019-06-25       Impact factor: 4.379

Review 6.  New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites.

Authors:  Xingxing Diao; Marilyn A Huestis
Journal:  Front Chem       Date:  2019-03-04       Impact factor: 5.545

7.  Nitroreduction of flutamide by Cunninghamella elegans NADPH: Cytochrome P450 reductase.

Authors:  Mohd Faheem Khan; Cormac D Murphy
Journal:  Biochem Biophys Rep       Date:  2022-01-17

Review 8.  Reviewing a plethora of oxidative-type reactions catalyzed by whole cells of Streptomyces species.

Authors:  Sara Salama; Mohamed H Habib; Rajni Hatti-Kaul; Yasser Gaber
Journal:  RSC Adv       Date:  2022-03-01       Impact factor: 3.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.